FDA revokes emergency use status of drug touted by Trump 

Editado por Ed Newman
2020-06-16 15:09:56

Pinterest
Telegram
Linkedin
WhatsApp

Washington, June 16 (RHC)-- The U.S. Food and Drug Administration, the FDA, has revoked the emergency use authorization for malaria drug hydroxychloroquine as a treatment for COVID-19, the use of which has been championed by U.S. President Donald Trump.

The FDA said based on new evidence, it was no longer reasonable to believe that oral formulations of hydroxychloroquine and the related drug chloroquine may be effective in treating COVID-19.
 



Comentários


Deixe um comentário
Todos os campos são requeridos
Não será publicado
captcha challenge
up